Industry News
GLP-1 Peptide Market to Reach $100B by 2030 — What It Means for Manufacturers

The global GLP-1 receptor agonist market is projected to exceed $100 billion by 2030, driven by obesity and type 2 diabetes treatment demand. As a leading GLP-1 peptide manufacturer, keruihk is positioned to support the growing need for high-purity GLP-1 APIs and analogs.
